Company intelligence / Profile preview

Quellent

United States

Ownership: Private
Development stage: Other

Overview

Quallent Pharmaceuticals, established in 2021, focuses on providing consistent, stable, and affordable access to medications for pharmacies and patients, with a particular emphasis on quality assurance in the pharmaceutical supply chain. The company's mission is to bring greater quality consistency and stability to the global pharmaceutical supply chain, ensuring reliable access to medication. Their activities center on commercial-stage generic pharmaceutical products, such as montelukast, rather than novel drug development or proprietary R&D.

Modalities: Small molecule
Industry: Biotech

Partnerships

Boehringer Ingelheim

Beyond the preview

Go deeper on Quellent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quellent.

Explore the full profile